Psychopharm 1

Create an educational illustration depicting various psychopharmacological drugs, their effects on the brain, and a psychologist engaging with patients, in a modern and informative style.

Psychopharmacology Proficiency Quiz

Test your knowledge of psychopharmacologic treatment options and drug mechanisms with our engaging quiz. Designed for psychology students and professionals alike, this quiz covers essential concepts and practical scenarios.

Assess your understanding of pharmacodynamics and pharmacokinetics.
Evaluate case studies on drug efficacy and safety.
Challenge yourself with multiple-choice questions tailored for aspiring psychologists.

14 Questions4 MinutesCreated by AnalyzingMind42

Which of the following is NOT an appropriate way for psychologists to aid in psychopharmacologic treatment?

Suggest a change in dosing for patient with poor drug compliance

Monitor side effects that the patient may experience

Identify symptoms that could be reduced by psychopharmacologic treatment

Monitor patient compliance with the current drug regimen

The components of pharmacodynamics include all of the following EXCEPT:

Distribution

Sensitization

Noncompetitive antagonism

Reuptake

If a drug company created a medication that was completely inactivated by first-pass metabolism, which of the following routes of administration would be ineffective to use?

Oral

Intravenous Injections

Sublingual

Inhalation

Drug A is capable of reducing most of the symptoms of depression in 70% of depressed patients at 50 mg per day. Drug B is capable of reducing most of the symptoms of depression in 60% of depressed patients at 40 mg/day. Drug C is capable of reducing most of the symptoms of depression in 50% of depressed patients at 100 mg/day. Which of these drugs has the greatest efficacy for treating depression symptoms?

Drug A

drug B

Drug C

They are all equal in efficacy

Drug X is capable of reducing most of the symptoms of depression in 30% of depressed patients at 50 mg per day. Drug Y is capable of reducing most of the symptoms of depression in 40% of depressed patients at 40 mg/day. Drug Z is capable of reducing most of the symptoms of depression in 50% of depressed patients at 100 mg/day. Which of these drugs has the greatest potency for treating depression symptoms?

Drug X

Drug Y

Drug Z

The are all equal in potency

All of the medications included in the class of drugs identified and marketed as atypical antipsychotics

Are more effective than the traditional or classic antipsychotics

Have lower side effect profiles than the traditional antipsychotics

Are more cost effective than the traditional antipsychotics

None of the above are true

What factors influence whether a drug will move from the stomach into the blood stream?

A. ionization

B. Lipid solubility

c. Down regulation (desensitization)

D. a. And b. Are true

Bob, the patient, takes two drugs, Drug X and Drug Y, and they both have high affinity for depot sites. Bob took Drug X first (say, earlier in the day). What do you predict will happen to the availability of Drug Y in the brain (assuming equal solubility and other things being the same)?

There will be higher concentrations of Drug Y

There will be higher concentrations of Drug X

There will be no effect on either drug

Both drugs will be increased in concentration

If an antagonist is available at a receptor site for a long period of time (weeks or more of taking a drug with this action), we would expect ______________________ to occur for receptors at the post synaptic site over time.

Down regulation

Up regulation

ionizaiton

Atrophy or cellular death

A receptor that opens directly upon contact with a ligand(s), allowing ions to flow into the post synaptic cell, is known as

Metabatropic

Phosphotropic

Ionotropic

Dopaminergic

For the next three questions, consider this vignette: Stella has been diagnosed with schizophrenia. She is showing muscular rigidity and some spasms in her neck. She developed these symptoms after starting a new drug, and these side effects came on fairly quickly (within a week). She states that she can’t stand feeling this way. First question: What is the name of these symptoms that Stella is experiencing?

Tardive dyskinesia

Extra pyramidal side effects

Galactorrhea

All of the above

For the next three questions, consider this vignette: Stella has been diagnosed with schizophrenia. She is showing muscular rigidity and some spasms in her neck. She developed these symptoms after starting a new drug, and these side effects came on fairly quickly (within a week). She states that she can’t stand feeling this way. Second question: What is your concern about the longer term use of this type of drug for Stella given this symptom presentation? (hint: think years, here)

Tardive dyskenesia

Extra pyramidal side effects

Drug dependence

All of the above

For the next three questions, consider this vignette: Stella has been diagnosed with schizophrenia. She is showing muscular rigidity and some spasms in her neck. She developed these symptoms after starting a new drug, and these side effects came on fairly quickly (within a week). She states that she can’t stand feeling this way. Third question: Given the concerns raised for Stella here, what drug would you guess she was placed on?

Stelazine (trifluoperazine)

Abilify (aripiprozole)

Haldol (haloperidol)

All of the above are true

Psychopharm 1

Psychopharmacology Proficiency Quiz

More Surveys